- Home
- ASPS vs FLNA Comparison
ASPS vs FLNA Comparison
Compare ASPS & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASPS | FLNA |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.8M | 61.8M |
| IPO Year | 2025 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ASPS | FLNA |
|---|---|---|
| Price | $5.43 | $0.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 6.5K | ★ 4.3M |
| Earning Date | 04-23-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $942,213,000.00 | $41,119,000.00 |
| Revenue This Year | $9.17 | N/A |
| Revenue Next Year | $24.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.30 | $0.67 |
| 52 Week High | $14.36 | $2.03 |
Technical Indicators
Market Signals| Indicator | ASPS | FLNA |
|---|---|---|
| Relative Strength Index (RSI) | 35.64 | 43.49 |
| Support Level | $5.00 | $0.67 |
| Resistance Level | $5.98 | $1.02 |
| Average True Range (ATR) | 0.23 | 0.09 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 2.53 | 12.86 |
Price Performance
Historical ComparisonAbout ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.
About FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.